SCHEMBL1574081

SCHEMBL1574081

CC1CCN(C(=O)n2nc(O)c3ccc([N+](=O)[O-])cc32)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
MAPT P10636 5/20 0.49
HPGD P15428 3/20 0.49
GAA P10253 1/20 0.48
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.43
CTSB P07858 1/20 0.42
LMNA P02545 2/20 0.42
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 1/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
KMT2A Q03164 1/20 0.41
F2 P00734 1/20 0.41
PLAU P00749 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573944 0.82 RAB9A (0.42) ALDH1A1MAPTHPGDHTTSMN1; SMN2
SCHEMBL1573858 0.82 MAPT (0.43) ALDH1A1MAPTHPGDHTTSMN1; SMN2
SCHEMBL5642345 0.79 MGLL (0.55) ALDH1A1MAPTHPGDGAAHTT
SCHEMBL1573842 0.79 ACHE (0.47) ALDH1A1MAPTHPGDGAASMN1; SMN2
SCHEMBL1573961 0.74 SMN1; SMN2 (0.39) ALDH1A1MAPTHPGDGAAHTT
SCHEMBL1574400 0.70 CTSB (0.44) ALDH1A1SMN1; SMN2CTSBCYP2C19CYP2C9
SCHEMBL1573644 0.69 RAB9A (0.39) ALDH1A1MAPTHPGDHTTSMN1; SMN2
SCHEMBL20952542 0.68 SMN1; SMN2 (0.56) ALDH1A1MAPTHPGDGAAHTT
SCHEMBL34464806 0.68 HTT (0.54) ALDH1A1MAPTHPGDGAAHTT
SCHEMBL1576556 0.68 ALDH1A1 (0.45) ALDH1A1MAPTHPGDGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968719-B2 Indazole derivatives as inhibitors of hormone sensitive lipase SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2011-06-28 US disclosed
EP-1713779-B1 INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE-SENSITIVE LIPASES SANOFI AVENTIS DEUTSCHLAND (DE) 2011-04-13 EP disclosed
US-20090215824-A1 INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE SENSITIVE LIPASE SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2009-08-27 US disclosed
US-7528155-B2 Indazole derivatives as inhibitors of hormone sensitive lipase SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2009-05-05 US disclosed
EP-1713779-A1 INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE-SENSITIVE LIPASES Sanofi-Aventis Deutschland GmbH (DE) 2006-10-25 EP disclosed
US-20050197348-A1 Indazole derivatives as inhibitors of hormone sensitive lipase AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-09-08 US disclosed
WO-2005073199-A1 INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE-SENSITIVE LIPASES SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215824-A1 INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE SENSITIVE LIPASE LIPE, PNLIP, CEL ALDH1A1 479/4885MAPT 4206/4885HPGD 291/4885
US-20050197348-A1 Indazole derivatives as inhibitors of hormone sensitive lipase LIPE, PNLIP, CEL ALDH1A1 479/4885MAPT 4206/4885HPGD 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.